Observational studyMultiple sclerosis (Houndmills, Basingstoke, England)2022

Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.

Zoë Ygj van Lierop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.